Dopamine system genes interaction and neurocognitive traits in patients with schizophrenia, their relatives and healthy controls from general population

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 106, Issue 7, 2006, Pages 57-63

  Alfimova, M V ^a   Golimbet, V E ^a   Gritsenko, I K ^a   Lezheiko, T V ^a   Abramova, L I ^a   Streltsova, M A ^a   Khlopina, I V ^a   Ebstein, R ^a  

^a NONE

Author keywords

Cognitive functioning; Dopamine; Gene polymorphism; Schizophrenia

Indexed keywords

DNA; DOPAMINE 4 RECEPTOR; DRD4 PROTEIN, HUMAN;

ADULT; ARTICLE; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MEMORY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; SCHIZOPHRENIA;

ADULT; COGNITION; COGNITION DISORDERS; DNA; FEMALE; GENOTYPE; HUMANS; MALE; MEMORY; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, DOPAMINE D4; SCHIZOPHRENIA;

EID: 33748523102     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Akil M., Kolachana B.S., Rothmond D.A. et al. Catechol-O-methyl- transferase genotype and dopamine regulation in the human brain. J Neurosci 2003; 23: 2008-2013.
2. Bearden C.E., Jawad A.F., Lynch D.R. et al. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiat 2004; 161: 1700-1702.
3. Bellgrove M.A., Hawi Z., Lowe N. et al. DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): Effects of associated alleles at the VNTR and -521 SNP. Am J Med Genet: B Neuropsychiatr Genet 2005; 136: 81-86.
4. Bertolino A., Caforio G., Blasi G. et al. Interaction of COMT [Val(108/158)Met] genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiat 2004; 161: 1798-1805.
5. Bilder R.M., Volavka J., Czobor P. et al. Neurocognitive correlates of the COMT (Val158Met)polymorphism in chronic schizophrenia. Biol Psychiat 2002; 52: 701-707.
6. Bilder R.M., Volavka J., Lachman H.M., Grace A.A. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004; 29: 1943-1961.
7. Buchanan R.W., Davis M., Goff D. et al. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 2005; 31: 5-19.
8. De Frias C.M., Annerbrink K., Westberg L. et al. COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav Genet 2004; 34: 533-539.
9. De Quervain D., Henke K., Aerni A. et al. A functional genetic variation of 5-HT2a receptor affects human memory. Nat Neurosci 2003; 6: 1141-1142.
10. Diamond A., Briand L., Fossella J., Gehlbach L. Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiat 2004; 161: 125-132.
11. Dreisbach G., Muller J., Goschke T. et al. Dopamine and cognitive control: the influence of spontaneous eyeblink rate and dopamine gene polymorphisms on perseveration and distractibility. Behav Neurosci 2005; 119: 483-490.
12. Egan M.F., Goldberg T.E., Kolachana B.S. et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-6922.
13. Emilien G., Maloteaux J.M., Geurts M., Owen M.J. Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology. Int J Neuropsychopharmacol 1999; 2: 197-227.
14. Fossella J., Sommer T., Fan J. et al. Assessing the molecular genetics of attention networks. BMC Neurosci 2002; 3: 14-21.
15. Glatt S.J., Faraone S.V., Tsuang M. T. Association between a functional catechol 0 methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiat 2003; 160: 469-476.
16. Goldberg T.E., Egan M.F., Gscheidle T. et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiat 2003; 60: 889-896.
17. Goldman-Rakic P.S., Selemon L.D. Frontal and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 1997; 23: 437-458.
18. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiat 2003; 160: 1-10.
19. Green M.F., Neuchterlein K.H. Should schizophrenia be treated as a neurocognitive disorder. Schizophr Bull 1999; 25: 309-318.
20. Ho B. C., Wassink T.H., O'Leary D.S. et al. Catechol-O-methyltransferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiat 2005; 10: 287-298.
21. Jonsson E.J., Goran C.S., Nothen M.M., Cichon S. Dopamine receptor gene (DRD4) variants and schizophrenia: meta-analyses. Schizophrenia Res 2003; 61: 111-119.
22. Joober R., Gauthier J., Lal S. et al. Catechol-O-methyltransferase Val108/158Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiat 2002; 59: 662-663.
23. Kremen W.S., Seidman L.J., Pepple J.R. et al. Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull 1994; 20: 103-119.
24. Lane H.Y., Lee C. C., Liu Y. C., Chang W.H. Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics. Pharmacogenomics 2005; 6: 139-149.
25. Mattay V.S., Goldberg T.E., Fera F. et al. Catechol-O-methyltransferase Val158Met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 2003; 100: 6186-6191.
26. Malhotra A.K., Kestler L.J., Mazzanti C. et al. Functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiat 2002; 159: 652-654.
27. Meador-Woodruff J.H., Haroutunian V., Powchik P. et al. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Arch Gen Psychiat 1997; 54: 1089-1095.
28. Okuyama Y., Ishiguro H., Toru M., Arinami T. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun 1999; 258: 292-295.
29. Palmatier M.A., Kang A.M., Kidd K.K. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiat 1999; 46: 557-567.
30. Rosa A., Peralta V., Cuesta M.J. et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiat 2004; 161: 1110-1112.
31. Sanger D.J. The search for novel antipsychotics: pharmacological and molecular targets. Expert Opin Ther Targets 2004; 8: 631-641.
32. Schmidt L.A., Fox N.A., Perez-Edgar K. et al. Association of DRD4 with attention problems in normal childhood development. Psychiat Genet 2001; 11: 25-29.
33. Serretti A., Macciardi P., Catalano M. et al. Genetic variants of dopamine receptor D4 and psychopathology. Schizophr Bull 1999; 25: 609-618.
34. Stefanis N. C., Van Os J., Avramopoulos D. et al. Variation in catechol-O-methyltransferase Val158Met genotype associated with schizotypy but not cognition: a population study in 543 young men. Biol Psychiat 2004; 56: 510-515.
35. Taerk E., Grizenko N., Ben Amor L. et al. Catechol-O-methyltransferase (COMT) Val108/158Met polymorphism does not modulate executive function in children with ADHD. BMC Med Genet 2004; 5: 30.
36. Toulopoulou Th., Murray R.M. Verbal memory deficit in patients with schizophrenia: an important future target for treatment. Expert Rev Neurother 2004; 4: 43-52.
37. Tsai S.J., Yu Y.W., Chen T.J. et al. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett 2003; 338: 123-126.
38. Wang X., Zhong P., Yan Z. Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J Neurosci 2002; 22: 9185-9193.
39. Weickert T.W., Goldberg T.E., Mishara A. et al. DR. Catechol-O- methyltransferase Val108/158Met genotype predicts working memory response to antipsychotic medications. Biol Psychiat 2004; 56: 677-682.
40. Weinberger D.R., Egan M.F., Bertolino A. et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiat 2001; 50: 825-844.
41. Zhang K., Grady C.J., Tsapakis E.M. et al. Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology 2004; 29: 1648-1655.